COVID cough app Hyfe launches in UK and IrelandA smartphone app that uses artificial intelligence to assess the sound of coughing has been launched in the Share XCOVID cough app Hyfe launches in UK and Irelandhttps://pharmaphorum.com/news/covid-cough-app-hyfe-launches-in-uk-and-ireland/
Does my cough sound like COVID? There could be an app for thatIt could be possible to detect whether someone has COVID-19 or not, just from the sound of their Share XDoes my cough sound like COVID? There could be an app for thathttps://pharmaphorum.com/news/does-my-cough-sound-like-covid-there-could-be-an-app-for-that/
Merck & Co plans to file cough drug gefapixant after phase 3 successMerck & Co is planning to file a drug for unexplained or treatment-resistant cough after supportive results from Share XMerck & Co plans to file cough drug gefapixant after phase 3 successhttps://pharmaphorum.com/news/merck-co-plans-to-file-cough-drug-gefapixant-after-phase-3-success/
Merck’s chronic cough drug gefapixant clears phase 3 testMerck & Co/MSD’s experimental drug gefapixant has improved the frequency of coughing in a pair of phase 3 Share XMerck’s chronic cough drug gefapixant clears phase 3 testhttps://pharmaphorum.com/news/mercks-chronic-cough-drug-gefapixant-clears-phase-3-test/
Merck to buy Afferent in potential $1.25 bn dealMerck to develop cough drug. Share XMerck to buy Afferent in potential $1.25 bn dealhttps://pharmaphorum.com/news/merck-buy-afferent-potential-1-25-bn-deal/
